GL1X · GenesisL1 explorer

Research workbench

Crystal structure of myst acetyltransferase domain in complex with inhibitor 74

Analyse Crystal structure of myst acetyltransferase domain in complex with inhibitor 74 in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6PDA
Type
protein
Length
268 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Histone acetyltransferase KAT8
EC
2.3.1.48
UniProt
Q9H7Z6
Ligands
O9J, ZN, NA, SO4
Pockets
3 · best druggability 0.70

Structure

x-ray diffraction · 1 distinct chain · 36% helix, 25% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AHistone acetyltransferase KAT8 (EC 2.3.1.48)protein26836% helix, 25% strandQ9H7Z6

Ligands and binding sites

  • O9J · 2-fluoro-3-methyl-N'-(phenylsulfonyl)-5-(pyridin-2-yl) benzohydrazide · ligand · chains A
  • ZN · Zinc ion · metal · chains A
  • NA · Sodium ion · metal · chains A
  • SO4 · Sulfate ion · ion · chains A
  • GOL · Glycerol · additive · 2 copies · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

3 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13470.700.8349GOL, O9J
2810.330.7515empty
3750.320.7420empty

Modifications

Observed in the structure: 1 modified (acetylation).

Compared structures

  • 6PDA · Crystal structure of MYST acetyltransferase domain in complex with inhibitor 74 · the same entry in another collection · chain A against A, TM-score 1.00
  • Q9H7Z6 · AlphaFold monomer V2.0 prediction for histone acetyltransferase KAT8 (Q9H7Z6) · a predicted model of the same protein · chain A against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.